Top Markets
Coin of the day
Wuhan Hiteck Biological Pharma Co.,Ltd Wuhan Hiteck Biological Pharma Co.,Ltd

Wuhan Hiteck Biological Pharma Co.,Ltd

300683
Rang in Aktien #13466
Wuhan Hiteck Biological Pharma Co.,Ltd is a biopharmaceutical enterprise... Wuhan Hiteck Biological Pharma Co.,Ltd is a biopharmaceutical enterprise operating in China, primarily engaged in the research, development, manufacturing, and commercialization of bio-engineered products and lyophilized injectable medications. The company's extensive product portfolio encompasses a variety of pharmaceutical solutions, such as Jinlujie, a mouse nerve growth factor for injection; omeprazole sodium for injection; cyclic adenosine phosphate; Xinye acyclovir tablets; Bingbing Horse & Dragon, an indomethacin furazolidone suppository; Xunkeyuan tinidazole suppository; and Shufu nimodipine sustained-release tablets. Beyond therapeutics, Wuhan Hiteck also provides a comprehensive array of diagnostic kits. These include tests for measles virus and rubella virus nucleic acid, mycoplasma isolation and identification, bacterial vaginosis rapid detection, measles virus IgG antibodies, and the coronavirus N-protein. Furthermore, the firm supplies active pharmaceutical ingredients (APIs) and their chemical intermediates, notably Lopinavir and Ritonavir. Its core therapeutic areas of focus are the nervous system and oncology. Established in 1992, Wuhan Hiteck Biological Pharma Co.,Ltd is headquartered in Wuhan, China.
Aktienkurs
$3.71
Marktkapitalisierung
$486.16M
Veränderung (1 Tag)
-0.97%
Veränderung (1 Jahr)
-45.64%
Land
CN
Handel Wuhan Hiteck Biological Pharma Co.,Ltd (300683)

Kategorie

Kursverlauf für Wuhan Hiteck Biological Pharma Co.,Ltd (300683)
Höchster Schlusskurs: $4.14 am 2026-08-01

Niedrigster Schlusskurs: $9.02 am 2017-08-01
Kursverlauf der Aktie von Wuhan Hiteck Biological Pharma Co.,Ltd von 2017 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 12.03%
2025 12.89%
2024 -29.37%
2023 -7.73%
2022 -31.14%
2021 20.37%
2020 60.25%
2019 2.10%
2018 -50.10%
2017 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$171.67 -
DE
$164.88 30.29%
DE
$37.61 25.11%
JP
$21.90 21.12%
IN
$218.36 25.22%
CH